gene Archive

Bluebird CEO defends $1.8 million gene therapy price — ‘It’s really thinking about it differently’

Bluebird Bio CEO Nick Leschly on Friday defended the biotech company’s $ 1.8 million price tag

Loup Ventures’ Gene Munster predicts a 10% blow to Google’s stock should Trump go after Big Tech

Google parent Alphabet could suffer a 10% blow to its stock should the U.S. government target

Commentary: Novartis CEO: Gene therapy offers hope of cures in a treatment, but US needs new pricing, payment model

We live in an incredible era of progress in human health. Advances in cell and gene

Doctors use HIV in gene therapy to fix ‘bubble boy’ disease

They were born without a working germ-fighting system, every infection a threat to their lives. Now

Netflix doesn’t have a good business model, says tech investor Gene Munster

Netflix had a “good enough quarter,” but the way it’s running its business leaves something to

Everybody's missing how Apple's 'subtle' approach could drive its stock higher, says Gene Munster

Apple‘s big event may have failed to impress investors on Monday — but those investors are

More streaming competition can negatively impact Netflix's multiple, Gene Munster says

Investors may be less willing to buy Netflix stock in two years as media companies such

Apple will be one of FAANG's best 2019 performers despite 'dark day': Gene Munster

Gene Munster is standing by his prediction that Apple will be one of the best FAANG

Apple bull Gene Munster: Apple stock will reach $350 in three years

Apple bull Gene Munster told CNBC on Wednesday if you “look through the noise” about the

Novartis CEO: 4 factors can help the industry price and pay for lifesaving cell and gene therapies

For decades now, the health-care industry, government and society have grown accustomed to a model for